The main aim of this clinical trial is to assess the safety of PJ009 in healthy adult volunteers aged 18-45. The main questions it aims to answer are:
* Is PJ009 safe in healthy adult? Participants will
* Receive single dose of PJ009 or placebo according to weight, and then multiple doses daily for 7 days,
* Stay in hospital for assessment.